Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib

被引：1

作者：

Mondoni, Michele ^{[1
]}

Varone, Francesco ^{[2
]}

Alfano, Fausta ^{[1
]}

Muscato, Giuseppe ^{[3
]}

Conti, Caterina ^{[4
]}

Saderi, Laura ^{[6
]}

Iovene, Bruno ^{[2
]}

Di Marco, Fabiano ^{[4
,5
]}

Vancheri, Carlo ^{[3
]}

Richeldi, Luca ^{[2
]}

Centanni, Stefano ^{[1
]}

Sotgiu, Giovanni ^{[6
]}

机构：

[1] Univ Milan, Dept Hlth Sci, ASST Santi Paolo & Carlo, Resp Unit, Milan, Italy

[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Div Pulm Med, Rome, Italy

[3] Univ Catania, Reg Referral Ctr Rare Lung Dis, AOU Policlin San Marco, Dept Clin & Expt Med, Catania, Italy

[4] ASST Papa Giovanni XXIII, Resp Unit, Bergamo, Italy

[5] Univ Milan, Dept Hlth Sci, Milan, Italy

[6] Univ Sassari, Dept Med Surg & Expt Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2023年 / 59卷 / 07期

关键词：

D O I：

10.1016/j.arbres.2023.02.010

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：464 / 466

页数：3

共 10 条

[1] Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Antoniou, Katerina
Markopoulou, Katerina
Tzouvelekis, Argyrios
Trachalaki, Athina
Vasarmidi, Eirini
Organtzis, Jiannis
Tzilas, Vasilios
Bouros, Evangelos
Kounti, Georgia
Rampiadou, Christina
Kotoulas, Serafeim-Chrysovalantis
Bardaka, Fotini
Bibaki, Eleni
Fouka, Evangelia
Meletis, Georgios
Tryfon, Stavros
Daniil, Zoe
Papakosta, Despina
Bouros, Demosthenes
[J]. ERJ OPEN RESEARCH, 2020, 6 (01)
[2] Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Behr, Juergen
Prasse, Antje
Wirtz, Hubert
Koschel, Dirk
Pittrow, David
Held, Matthias
Klotsche, Jens
Andreas, Stefan
Claussen, Martin
Grohe, Christian
Wilkens, Henrike
Hagmeyer, Lars
Skowasch, Dirk
Meyer, Joachim F.
Kirschner, Joachim
Glaeser, Sven
Kahn, Nicolas
Welte, Tobias
Neurohr, Claus
Schwaiblmair, Martin
Bahmer, Thomas
Oqueka, Tim
Frankenberger, Marion
Kreuter, Michael
[J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)
[3] Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis
Flaherty, Kevin R.
Kolb, Martin
Vancheri, Carlo
Tang, Wenbo
Conoscenti, Craig S.
Richeldi, Luca
[J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
[4] Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Hambly, Nathan
Farooqi, M. Malik
Dvorkin-Gheva, Anna
Donohoe, Kathryn
Garlick, Kristopher
Scallan, Ciaran
Chong, Sy Giin
MacIsaac, Sarah
Assayag, Deborah
Johannson, Kerri A.
Fell, Charlene D.
Marcoux, Veronica
Manganas, Helene
Morisset, Julie
Comes, Alessia
Fisher, Jolene H.
Shapera, Shane
Gershon, Andrea S.
To, Teresa
Wong, Alyson W.
Sadatsafavi, Mohsen
Wilcox, Pierce G.
Halayko, Andrew J.
Khalil, Nasreen
Cox, Gerard
Richeldi, Luca
Ryerson, Christopher J.
Kolb, Martin
[J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (04)
[5] Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 Years
Mondoni, Michele
Alfano, Fausta
Varone, Francesco
Muscato, Giuseppe
Conti, Caterina
Saderi, Laura
Chiesa, Amerigo
Di Marco, Fabiano
Vancheri, Carlo
Richeldi, Luca
Centanni, Stefano
Sotgiu, Giovanni
[J]. RESPIRATION, 2023, 102 (01) : 25 - 33
[6] Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study
Poletti, V.
Vancheri, C.
Albera, C.
Harari, S.
Pesci, A.
Metella, R. R.
Campolo, B.
Crespi, G.
Rizzoli, S.
[J]. RESPIRATORY RESEARCH, 2021, 22 (01)
[7] Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, Ganesh
Remy-Jardin, Martine
Richeldi, Luca
Thomson, Carey C.
Inoue, Yoshikazu
Johkoh, Takeshi
Kreuter, Michael
Lynch, David A.
Maher, Toby M.
Martinez, Fernando J.
Molina-Molina, Maria
Myers, Jeffrey L.
Nicholson, Andrew G.
Ryerson, Christopher J.
Strek, Mary E.
Troy, Lauren K.
Wijsenbeek, Marlies
Mammen, Manoj J.
Hossain, Tanzib
Bissell, Brittany D.
Herman, Derrick D.
Hon, Stephanie M.
Kheir, Fayez
Khor, Yet H.
Macrea, Madalina
Antoniou, Katerina M.
Bouros, Demosthenes
Buendia-Roldan, Ivette
Caro, Fabian
Crestani, Bruno
Ho, Lawrence
Morisset, Julie
Olson, Amy L.
Podolanczuk, Anna
Poletti, Venerino
Selman, Moises
Ewing, Thomas
Jones, Stephen
Knight, Shandra L.
Ghazipura, Marya
Wilson, Kevin C.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (09) : E18 - E47
[8] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, Luca
du Bois, Roland M.
Raghu, Ganesh
Azuma, Arata
Brown, Kevin K.
Costabel, Ulrich
Cottin, Vincent
Flaherty, Kevin R.
Hansell, David M.
Inoue, Yoshikazu
Kim, Dong Soon
Kolb, Martin
Nicholson, Andrew G.
Noble, Paul W.
Selman, Moises
Taniguchi, Hiroyuki
Brun, Michele
Le Maulf, Florence
Girard, Mannaig
Stowasser, Susanne
Schlenker-Herceg, Rozsa
Disse, Bernd
Collard, Harold R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) : 2071 - 2082
[9] Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases
Swigris, Jeffrey J.
Bushnell, Donald M.
Rohr, Klaus
Mueller, Heiko
Baldwin, Michael
Inoue, Yoshikazu
[J]. BMJ OPEN RESPIRATORY RESEARCH, 2022, 9 (01)
[10] Nintedanib for the treatment of idiopathic pulmonary fibrosis
Varone, Francesco
Sgalla, Giacomo
Iovene, Bruno
Bruni, Teresa
Richeldi, Luca
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (02) : 167 - 175

← 1 →